Targeted Cancer Therapy

Boston, Massachusetts, U.S., and Vancouver, British Columbia, Canada, September 8, 2026 Alpha-9 Oncology has announced the dosing of the...

Detroit, Michigan, August 31, 2026 The Barbara Ann Karmanos Cancer Institute announced that it is now offering FDA-approved daraxonrasib...

Hong Kong, August 21, 2026 Akeso, Inc. has announced that its investigational B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received...

Garching/Munich, Germany and Princeton, New Jersey – July 27, 2026 ITM Isotope Technologies Munich SE (ITM) has launched Lumara...

NEW YORK, May 13, 2026 Nuvation Bio announced a strategic collaboration with Thermo Fisher Scientific to establish U.S.-based manufacturing...

Minneapolis, USA – March 9, 2026 Celcuity Inc. has announced the publication of positive Phase 3 VIKTORIA-1 clinical trial...